Addressing challenges in treating rare tumours: the strategy of China’s National Cancer Center2026-07-090 PRE AI SShuhang Wang *JJiawei Zhou HHanqing He PPeiwen Ma YYale Jiang NNing Li * DOI:10.1038/s41573-026-01484-6OriginalOriginal request for helpShareSaveAbstract En